NAPA Extends Partnership with iProcedures
TAMPA, Fla.--(BUSINESS WIRE)--#AIMS--iProcedures, LLC announced today that North American Partners in Anesthesia (NAPA) has selected iProcedures as its Anesthesia Information...
Staff
Key Capital Launches MaxCellLife.com to Market Unique Supplement and Skincare Products
Jennifer Reilly appointed Marketing Director to Lead MaxCellLife.com Launch NEW YORK, NY / ACCESSWIRE / April 7, 2021 / KEY...
CLS Holdings USA, Inc. President and COO Andrew Glashow Featured On The Stock Day Podcast
LAS VEGAS, NV / ACCESSWIRE / April 7, 2021 / The Stock Day Podcast welcomed CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH),...
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning...
AmeriCann Announces Record Breaking Quarterly Revenue
The Company Provided an Operations Update About the Increased Sales Growth at its Flagship Massachusetts Cannabis Center BOSTON, MA /...
GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform
GBS' newest proprietary drug discovery platform uses data analytics and machine learning to gain valuable predictive insights into the likely...
Jushi Holdings Inc. to Present at PI Financial Golden State Green: Going Deep into the California Cannabis Market Conference on April 14, 2021
BOCA RATON, Fla., April 07, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
NKGen Biotech Announces Appointment of Philip Moody as Chief Financial Officer
SANTA ANA, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- NKGen Biotech, a biotechnology company harnessing the power of the body's...
Broward Health Medical Center Becomes First Hospital in Florida to Adopt Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
ST. LOUIS, April 07, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting
Adds to growing body of published research supporting the development of non-viral TCR-T therapies for the treatment of epithelial cancersBOSTON...
Cannabix Technologies to Beta Test Marijuana Breathalyzer with Private Clinic in Northwestern U.S.
Cannabix is developing the Cannabix Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety...
Homology Medicines Announces Pricing of Public Offering of Common Stock
BEDFORD, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, today announced the...
LifeMD Launches NavaMD™ Adding Direct-to-Patient Clinical Skincare Services to its Portfolio of Personalized Telehealth Brands
The brand launch into tele-dermatology adds further portfolio diversification into exciting and fast-growing area of patient healthcareNEW YORK, April 07,...
ChemoCentryx to Host Virtual R&D Day on April 14, 2021
MOUNTAIN VIEW, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that it will host a...
Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on...
CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
BERKELEY HEIGHTS, N.J., April 07, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
ERC-USA Announces FDA Recommendation for Early Termination of Phase 2 Clinical Trial of ERC1671 (Gliovac or Sitoiganap) and Application for Registration Trial for Treatment of Glioblastoma
IRVINE, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- ERC-USA and the University of California, Irvine (UCI), today announce that the...
Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases
Data from Initial Patient Cohorts of Phase 2 AFFINITY Study Expected to be Reported in 2022 SEATTLE, April 07, 2021...
Cidara Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
SmileDirectClub Announces New Lifetime Smile Guarantee™
Industry-First Program Bolsters Customer Experience, Giving Teeth Straightening Customers Straighter, Healthier Smiles for LifeNASHVILLE, Tenn., April 07, 2021 (GLOBE NEWSWIRE)...